Skip to main content

stendra

Generic: avanafil

stendra: developed by 2 companies · 1 FDA decision.

stendra evidence translation

What we can confirm

1 FDA record

What it means

More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

What is verified about stendra, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

Erectile dysfunction (ED)Erectile dysfunction

Study sponsors

No additional listed-company sponsor is linked.

Development Pipeline (2)
CompanyPhase
Petros Pharmaceuticals, Inc. (PTPI)
Erectile dysfunction (ED)
Approved
VIVUS INC (VVUS)
Erectile dysfunction
Approved
FDA Decisions1 records
NDA202276Type 1 - New Molecular EntityStandardOralTablet

Frequently asked questions

Who is developing stendra?

stendra is being developed by Petros Pharmaceuticals, Inc., VIVUS INC.

What is stendra's latest FDA decision?

The most recent tracked FDA decision for stendra is Approval, dated April 27, 2012.